Effectiveness of lamotrigine in maintaining symptom control in pediatric bipolar disorder

Journal of Child and Adolescent Psychopharmacology

Volumn 19, Issue 1, 2009, Pages 75-82

  Pavuluri, Mani N ^a,b   Henry, David B ^a   Moss, Melissa ^a   Mohammed, Tahseen ^a   Carbray, Julie A ^a   Sweeney, John A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Institute for Juvenile Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; BENZATROPINE; LAMOTRIGINE; PREDNISONE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

ADOLESCENT; ADULT; ARTICLE; BIPOLAR DISORDER; CHILD; CHILDREN DEPRESSION RATING SCALE REVISED; CLINICAL ARTICLE; CLINICAL TRIAL; DEPRESSION; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ERYTHEMA MULTIFORME; FEMALE; FEVER; HUMAN; HYPOMANIA; INCREASED APPETITE; MALAISE; MALE; MANIA; MICTURITION; MIXED MANIA AND DEPRESSION; MONOTHERAPY; PEDIATRICS; RASH; RATING SCALE; REMISSION; SCHOOL CHILD; SEDATION; SIDE EFFECT; STOMACH PAIN; WEIGHT GAIN; YOUNG MANIA RATING SCALE;

ADOLESCENT; ANTIMANIC AGENTS; BIPOLAR DISORDER; CHILD; DEPRESSIVE DISORDER; FEMALE; HUMANS; LONG-TERM CARE; MALE; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME; TRIAZINES;

EID: 60749122652     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.2008.0107     Document Type: Article

References (35)

1. th edition (DMA-IV). Washington (DC): American Psychiatric Association, 1994.
2. Anand A, Oren DA, Berman RM, Cappiello A, Charney DS: Lamotrigine treatment of lithium failure outpatient mania - a double-blind, placebo-controlled trial. In: Bipolar Disorders, Abstract Book, Third International Conference on Bipolar Disorder, Pittsburgh, PA, June 17-19. Edited by Soares JC, Gershon S. Munksgaard, Copenhagen, 1999, p 23.
3. Anand A, Charney DS, Oren DA, Berman RM, Hu XS, Cappiello A, Krystal JH: Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: Support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists. Arch Gen Psychiatry 57:270-276, 2000.
4. Biederman J, Faraone S, Mick E, Wozniak J, Chen L, Ouellette C, Marrs A, Moore P, Garcia J, Mennin D, Lelon E: Attention-deficit hyperactivity disorder and juvenile mania: An overlooked comorbidity? J Am Acad Child Adolesc Psychiatry 35:997-1008, 1996.
5. Bowden CL, Calabrese JR, Sachs G, Yatham LN, Asghar SA, Hompland M, Montgomery P, Earl N, Smoot TM, DeVeaugh-Geiss J: A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 60:392-400, 2003.
6. Calabrese JR, Suppes T, Bowden CL, Sachs GS, Swann AC, McElroy SL, Kusumakar V, Ascher JA, Earl NL, Greene PL, Monaghan ET: A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry 61:841-850, 2000.
7. Calabrese JR, Bowden CL, Sachs G, Yatham LN, Behnke K, Mehtonen OP, Montgomery P, Ascher J, Paska W, Earl N, DeVeaugh-Geiss J: A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 64:1013-1024, 2003.
8. Carandang CG, Maxwell DJ, Robbins DR, Oesterheld JR: Lamotrigine in adolescent mood disorders. J Am Acad Child Adolesc Psychiatry 42:750-751, 2003.
9. Chang K, Saxena K, Howe M: An open-label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression. J Am Acad Child Adolesc Psychiatry 45:298-304, 2006.
10. Chou JC, Fazzio L: Maintenance treatment of bipolar disorder: Applying research to clinical practice. J Psychiatr Pract 12:283-299, 2006.
11. Deakin JF, Lees J, McKie S, Hallak JE, Williams SR, Dursun SM: Glutamate and the neural basis of the subjective effects of ketamine: A pharmaco-magnetic resonance imaging study. Arch Gen Psychiatry 65:154-164, 2008.
12. Findling RL, McNamara NK, Youngstrom EA, Stansbrey R, Gracious BL, Reed MD, Calabrese JR: Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry 44:409-417, 2005.
13. Fisher LD, Dixon DO, Herson J, Frankowski RK, Hearon MS, Pearce KE: Intention to treat in clinical trials. In: Statistical Issues in Drug Research and Development. Edited by Pearce KE. New York, Marcel Dekker, 1990, pp 331-350.
14. Frazier JA, Biederman J, Tohen M, Feldman PD, Jacobs TG, Toma V, Rater MA, Tarazi RA, Kim GS, Garfield SB, Sohma M, Gonzalez-Heydrich J, Risser RC, Nowlin ZM: A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J Child Adolesc Psychopharmacol 11:239-250, 2001.
15. Frye MA, Ketter TA, Kimbrell TA, Dunn RT, Speer AM, Osuch EA, Luckenbaugh DA, Cora-Ocatelli G, Leverich GS, Post RM: A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 20:607-614, 2000.
16. Geller B, Warner K, Williams M, Zimerman B: Prepubertal and young adolescent bipolarity versus ADHD: Assessment and validity using the WASH-U-KSADS, CBCL, and TRF. J Affect Disord 51:93-100, 1998.
17. Goldberg JF, Bowden CL, Calabrese JR, Ketter TA, Dann RS, Frye MA, Suppes T, Post RM: Six-month prospective life charting of mood symptoms with lamotrigine monotherapy versus placebo in rapid cycling bipolar disorder. Biol Psychiatry 63:125-130, 2008.
18. Goodwin GM, Bowden CL, Calabrese JR, Grunze H, Kasper S, White R, Greene P, Leadbetter R: A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder. J Clin Psychiatry 65:432-441, 2004.
19. Gor DO, Rose NR, Greenspan NS: TH1-TH2: A procrustean paradigm. Nat Immunol 4:503-505, 2003.
20. Guberman AH, Besag FM, Brodie MJ, Dooley JM, Duchowny MS, Pellock JM, Richens A, Stern RS, Trevathan E: Lamotrigine-associated rash: Risk/benefit considerations in adults and children. Epilepsia 40:985-991, 1999.
21. Ichim L, Berk M, Brook S: Lamotrigine compared with lithium in mania: A double-blind randomized controlled trial. Ann Clin Psychiatry 12:5-10, 2000.
22. Kamogawa Y, Minasi LA, Carding SR, Bottomly K, Flavell RA: The relationship of IL-4- and IFN gamma-producing T cells studied by lineage ablation of IL-4-producing cells. Cell 75:985-995, 1993.
23. Korstanje C: The T-helper1/T-helper2 paradigm: still valid for drug discovery but with some essential refinement. Curr Opin Investig Drugs 5:487-488, 2004.
24. Kusumakar V, Yatham LN: An open study of lamotrigine in refractory bipolar depression. Psychiatry Res 72:145-148, 1997.
25. Martin P, Carlsson ML, Hjorth S: Systemic PCP treatment elevates brain extracellular 5-HT: A microdialysis study in awake rats. Neuroreport 9:2985-2988, 1998.
26. Messenheimer JA: Rash in adult and pediatric patients treated with lamotrigine. Can J Neurol Sci 25:S14-S18, 1998.
27. Millan MJ, Brocco M, Gobert A, Joly F, Bervoets K, Rivet J, Newman-Tancredi A, Audinot V, Maurel S: Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: Importance of nucleus accumbens 5-HT2A sites for PCP-induced locomotion in the rat. Eur J Neurosci 11:4419-4432, 1999.
28. Pavuluri MN, Birmaher B, Naylor MW: Pediatric bipolar disorder: A review of the past 10 years. J Am Acad Child Adolesc Psychiatry 44:846-871, 2005.
29. Pavuluri MN, Henry DB, Carbray JA, Sampson GA, Naylor MW, Janicak PG: A one-year open-label trial of risperidone augmentation in lithium nonresponder youth with preschool-onset bipolar disorder. J Child Adolesc Psychopharmacol 16:336-350, 2006.
30. Poznanski E, Grossman J, Buchsbaum Y, Banegas M, Freeman L, Gibbons R: Preliminary studies of the reliability and validity of the children's depression rating scale. J Am Acad Child Adolesc Psychiatry 23:191-197, 1984.
31. Singh VK, Mehrotra S, Agarwal SS: The paradigm of Th1 and Th2 cytokines: Its relevance to autoimmunity and allergy. Immunol Res 20:147-161, 1999.
32. Spearing MK, Post RM, Leverich GS, Brandt D, Nolen W: Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): The CGI-BP. Psychiatry Res 73:159-171, 1997.
33. Suppes T, Marangell LB, Bernstein IH, Kelly DI, Fischer EG, Zboyan HA, Snow DE, Martinez M, Al Jurdi R, Shivakumar G, Sureddi S, Gonzalez R: A single blind comparison of lithium and lamotrigine for the treatment of bipolar II depression. J Affect Disord Epub March 19, 2008.
34. Theberge J, Bartha R, Drost DJ, Menon RS, Malla A, Takhar J, Neufeld RW, Rogers J, Pavlosky W, Schaefer B, Densmore M, Al Semaan Y, Williamson PC: Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. Am J Psychiatry 159:1944-1946, 2002.
35. Young RC, Biggs JT, Ziegler VE, Meyer DA: A rating scale for mania: Reliability, validity and sensitivity. Br J Psychiatry 133:429-435, 1978.